A phase II trial of reirradiation combined with pembrolizumab in patients with locoregional inoperable recurrence or second primary squamous cell carcinoma of the head and neck (HNSCC)

被引：0
|
作者：
Zandberg, Dan Paul
Bauman, Jessica R.
Mehra, Ranee
Molitoris, Jason K.
Jelinek, Mark
Wang, Hong
Clump, David Anthony, II
Skinner, Heath Devin
Ferris, Robert L.
Fenton, Moon Jung
Cullen, Kevin J.
Suntharalingam, Mohan
Bentzen, Soren
Giri, Anshu
Liu, Jeffrey C.
Galloway, Thomas James
机构：
[1] Univ Pittsburgh, UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[2] Temple Univ Hlth Syst, Fox Chase Canc Ctr, Philadelphia, PA USA
[3] Univ Maryland, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD USA
[4] Univ Maryland, Baltimore, MD USA
[5] UPMC Hillman Canc Ctr Biostat Facil, Pittsburgh, PA USA
[6] Univ Pittsburgh, Pittsburgh, PA USA
[7] UPMC Hillman Canc Ctr, Pittsburgh, PA USA
[8] UPMC Hillman Canc Ctr, Dept Radiat Oncol, Pittsburgh, PA USA
[9] Univ Maryland, Dept Med, Baltimore, MD USA
[10] Univ Maryland, Sch Med, Baltimore, MD USA
[11] Fox Chase Canc Ctr, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6049
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phase II trial evaluating the efficacy of pembrolizumab combined with vorinostat in patients with recurrent and/or metastatic head & neck squamous cell carcinoma - subgroup analysis of the PEVOsq basket trial
    Le Tourneau, C.
    Ghiringhelli, F.
    Saada, E. B.
    Chaltiel, R.
    Vansteene, D.
    Durando, X.
    You, B.
    Borel, C.
    Bigot, F.
    Abdeddaim, C.
    Marret, G.
    Jeannot, E.
    Rocco, E. Guerini
    Frige, G.
    Servant, N.
    Dupain, C.
    Kamal, M.
    Legrand, F.
    Jimenez, M.
    Filleron, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S583 - S583
  • [22] Locoregional Recurrence of an HPV-Positive Squamous Cell Carcinoma of the Head and Neck
    Bowles, Daniel W.
    Reddy, Krishna
    Wine, Todd
    Ree, Alexander
    Raben, David
    Chen, Changhu
    Jimeno, Antonio
    ONCOLOGY-NEW YORK, 2011, 25 (11): : 1042 - 1048
  • [23] Reirradiation for patients with recurrence head and neck squamous cell carcinoma: A single-institution comparative study
    Rudzianskas, Viktoras
    Inciura, Arturas
    Vaitkus, Saulius
    Padervinskis, Evaldas
    Rudzianskiene, Milda
    Kupcinskaite-Noreikiene, Rita
    Saltonaite, Lina
    Noreika, Alius
    Statnickaite, Akvile
    Juozaityte, Elona
    MEDICINA-LITHUANIA, 2014, 50 (02): : 92 - 99
  • [24] Phase II trial of valproic acid combined with cisplatin-based chemoradiation in locally advanced (LA) head and neck squamous cell carcinoma (HNSCC) patients (pts).
    Mak, Milena Perez
    Pasini, Fatima Solange
    Diao, Lixia
    Garcia, Fabyane Oliveira Teixeira
    Takahashi, Tiago Kenji
    Amadio, Alex Vitorio
    Siqueira, Sheila Aparecida Coelho
    Sichero, Laura
    Snitcovsky, Igor M. L.
    Kulcsar, Marco Aurelio Vamondes
    Wang, Jing
    Castro, Gilberto
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Pembrolizumab and cabozantinib in recurrent metastatic head and neck squamous cell carcinoma: a phase 2 trial
    Saba, Nabil F.
    Steuer, Conor E.
    Ekpenyong, Asari
    McCook-Veal, Ashley
    Magliocca, Kelly
    Patel, Mihir
    Schmitt, Nicole C.
    Stokes, William
    Bates, James E.
    Rudra, Soumon
    Remick, Jill
    McDonald, Mark
    Abousaud, Marin
    Tan, Aik Choon
    Fadlullah, Muhammad Zaki Hidayatullah
    Chaudhary, Ritu
    Muzaffar, Jameel
    Kirtane, Kedar
    Liu, Yuan
    Chen, Georgia Z.
    Shin, Dong M.
    Teng, Yong
    Chung, Christine H.
    NATURE MEDICINE, 2023, 29 (04) : 880 - 887
  • [26] Intensity-Modulated Reirradiation Therapy With Nivolumab in Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma A Nonrandomized Controlled Trial
    Saba, Nabil F.
    Wong, Stuart J.
    Nasti, Tahseen
    McCook-Veal, Ashley Alesia
    Mcdonald, Mark W.
    Stokes, William A.
    Anderson, Allyson M.
    Ekpenyong, Asari
    Rupji, Manali
    Abousaud, Marin
    Rudra, Soumon
    Bates, James E.
    Remick, Jill S.
    Joshi, Nikhil P.
    Woody, Neil M.
    Awan, Musaddiq
    Geiger, Jessica L.
    Shreenivas, Aditya
    Samsa, Julia
    Ward, Matthew Christopher
    Schmitt, Nicole C.
    Patel, Mihir R.
    Higgins, Kristin A.
    Teng, Yong
    Steuer, Conor E.
    Shin, Dong M.
    Liu, Yuan
    Ahmed, Rafi
    Koyfman, Shlomo A.
    JAMA ONCOLOGY, 2024, 10 (07) : 896 - 904
  • [27] POPPY: A phase II trial to assess the efficacy and safety profile of pembrolizumab in patients of performance status 2 with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M HNSCC)
    Forster, M. D.
    Mason, J.
    Moleron, R.
    Sacco, J. J.
    Beasley, M.
    Ferreira, M. Reis
    Srinivasan, D.
    Yip, K.
    Stewart, G.
    Chiu, K.
    Ward, A.
    Metcalf, R.
    Adedoyin, T.
    Begum, R.
    Chiwewe, M.
    Poole, K.
    Spanswick, V.
    Pathak, Y.
    Counsell, N.
    Rashid, M. K.
    ANNALS OF ONCOLOGY, 2024, 35 : S623 - S624
  • [28] Effect of a second primary thyroid carcinoma on patients with head and neck squamous cell carcinoma
    Tolisano, Anthony M.
    Klem, Christopher
    Lustik, Michael B.
    Sniezek, Joseph C.
    Golden, J. Blake
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2016, 38 : E890 - E894
  • [29] A phase II trial of vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Saxman, S
    Mann, B
    Canfield, V
    Loehrer, P
    Vokes, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1998, 21 (04): : 398 - 400
  • [30] Pembrolizumab in Patients with Refractory Cutaneous Squamous Cell Carcinoma: A Phase II Trial
    Renata Ferrarotto
    Luana G. Sousa
    Yun Qing
    Diana Kaya
    Bettzy Stephen
    Dipti Jain
    Diana Bell
    Shubham Pant
    Apostolia M. Tsimberidou
    Filip Janku
    George Blumenschein
    Bonnie S. Glisson
    Jordi Rodon Ahnert
    Sarina A. Piha-Paul
    J. Jack Lee
    Michael K. Wong
    Charles Lu
    Funda Meric-Bernstam
    Aung Naing
    Advances in Therapy, 2021, 38 : 4581 - 4591
12345